awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34949678-719FE749-ED05-45FE-935E-54E2E920F792
Q34949678-719FE749-ED05-45FE-935E-54E2E920F792
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34949678-719FE749-ED05-45FE-935E-54E2E920F792
Combined anticancer effects of sphingosine kinase inhibitors and sorafenib.
P356
Q34949678-719FE749-ED05-45FE-935E-54E2E920F792
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34949678-719FE749-ED05-45FE-935E-54E2E920F792
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
25d135e79bc9f173c76a37547eba5601b3fb611f
P356
10.1007/S10637-010-9452-0
http://www.w3.org/2001/XMLSchema#string
P356
S10637-010-9452-0